Director/Senior Director, NewCo Build & Strategic Execution

<div class="content-intro"><p><strong>About Raven:</strong><br>We are Raven, RA Capital’s healthcare incubator. From discovery to delivery, whether we incubate, accelerate or rejuvenate, Raven’s goal is to turn scientific breakthroughs into transformative therapies and get them quickly, safely and efficiently to the patients that need them most. Raven’s experienced scientists, operators, and healthcare innovators have deep sector expertise across therapeutics, diagnostics, devices and services. They have brought hundreds of therapeutics into development, managed hospital systems, optimized clinical trials and navigated payor and regulatory systems to deliver patient impact - and they are ready to work with you.<br><br><strong>About RA Capital:</strong><br>Founded in 2004, RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital's knowledge engine is guided by our Tech Atlas internal research division, and Raven, RA Capital’s company building team, offers entrepreneurs and innovators a collaborative and comprehensive platform to explore the novel and the re-imagined. RA Capital has more than 150 employees and over $10 billion in assets under management.</p></div><p>Role Overview<br>We are seeking a highly execution-driven leader to structure, build, and operationalize multiple NewCos. These companies will typically be formed around assets or teams transitioning from another geography, institution, or parent organization. This role is responsible for turning scientific assets into operationally disciplined, financing-ready biotech companies. This individual will architect repeatable company-build frameworks, manage cross-border transitions, and ensure each NewCo launches with strong program governance, operational rigor, and Board-ready reporting. This is a high-accountability role at the intersection of company creation, program execution, and strategic operations.</p> <p>Core Mandate<br>For each NewCo:</p> <ul> <li>Structure the build</li> <li>Execute asset/team transition</li> <li>Establish operating discipline</li> <li>Implement program management frameworks</li> <li>Drive vendor and development execution</li> <li>Ensure financing readiness</li> <li>Ensure cross-company visibility and milestone tracking</li> </ul> <p>Key Responsibilities<br>1. NewCo Formation Transition Execution</p> <ul> <li>Lead operational structuring of 1-3 NewCos in parallel<br>-Drive asset and data transition (IP, preclinical data, regulatory documentation, contracts). Coordinate geographic transitions (team, vendor, regulatory alignment). Ensure clean legal and contractual handoffs in coordination with outside counsel. Stand up initial governance and operating processes.</li> </ul> <p>2. Program Portfolio Infrastructure</p> <ul> <li>Establish program management framework within each NewCo:<br>Integrated timelines<br>Budget visibility<br>Cross-functional milestone tracking<br>Risk dashboards<br>Align development plans with financing and value-inflection milestones<br>Ensure consistent reporting cadence across companies<br>Create portfolio-level visibility across all active projects</li> </ul> <p>3. Vendor External Network Governance</p> <ul> <li>Structure and manage CRO, CDMO, and lab engagements</li> <li>Standardize vendor selection, onboarding, and performance tracking</li> <li>Drive accountability and cost control across external partners</li> <li>Ensure development plans translate into executable vendor scopes</li> </ul> <p>4. Operations Executive Support (Embedded Chief of Staff Function)</p> <ul> <li>Structure executive team meetings and action tracking</li> <li>Support Board preparation and milestone reporting ... (truncated, view full listing at source)